company background image
4108

PhytoHealth TWSE:4108 Stock Report

Last Price

NT$19.80

Market Cap

NT$3.9b

7D

3.1%

1Y

-21.7%

Updated

24 May, 2022

Data

Company Financials
4108 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

4108 Stock Overview

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products.

Risk Analysis

No risks detected for 4108 from our risk checks.

PhytoHealth Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for PhytoHealth
Historical stock prices
Current Share PriceNT$19.80
52 Week HighNT$26.60
52 Week LowNT$19.00
Beta0
1 Month Change-10.41%
3 Month Change-7.69%
1 Year Change-21.74%
3 Year Change3.94%
5 Year Change-30.04%
Change since IPO-65.86%

Recent News & Updates

Shareholder Returns

4108TW PharmaceuticalsTW Market
7D3.1%3.1%1.5%
1Y-21.7%2.8%-0.7%

Return vs Industry: 4108 underperformed the TW Pharmaceuticals industry which returned 2.8% over the past year.

Return vs Market: 4108 underperformed the TW Market which returned -0.7% over the past year.

Price Volatility

Is 4108's price volatile compared to industry and market?
4108 volatility
4108 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement4.6%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4108 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 4108's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998n/aI-Lin Leehttps://www.phytohealth.com.tw

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services.

PhytoHealth Fundamentals Summary

How do PhytoHealth's earnings and revenue compare to its market cap?
4108 fundamental statistics
Market CapNT$3.94b
Earnings (TTM)-NT$80.71m
Revenue (TTM)NT$178.72m

22.0x

P/S Ratio

-48.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4108 income statement (TTM)
RevenueNT$178.72m
Cost of RevenueNT$94.16m
Gross ProfitNT$84.56m
Other ExpensesNT$165.27m
Earnings-NT$80.71m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.41
Gross Margin47.32%
Net Profit Margin-45.16%
Debt/Equity Ratio0%

How did 4108 perform over the long term?

See historical performance and comparison

Valuation

Is PhytoHealth undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


2x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 4108's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 4108's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: 4108 is unprofitable, so we can't compare its Price-To-Earnings Ratio to the TW Pharmaceuticals industry average.

PE vs Market: 4108 is unprofitable, so we can't compare its Price-To-Earnings Ratio to the TW market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4108's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 4108's Price-To-Book Ratio (2x) is in line with the TW Pharmaceuticals industry average.


Future Growth

How is PhytoHealth forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


52.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PhytoHealth has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has PhytoHealth performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


16.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4108 is currently unprofitable.

Growing Profit Margin: 4108 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 4108 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.7% per year.

Accelerating Growth: Unable to compare 4108's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4108 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-2%).


Return on Equity

High ROE: 4108 has a negative Return on Equity (-4%), as it is currently unprofitable.


Financial Health

How is PhytoHealth's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: 4108's short term assets (NT$1.6B) exceed its short term liabilities (NT$36.0M).

Long Term Liabilities: 4108's short term assets (NT$1.6B) exceed its long term liabilities (NT$23.9M).


Debt to Equity History and Analysis

Debt Level: 4108 is debt free.

Reducing Debt: 4108 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 4108 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 4108 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 35.1% each year


Dividend

What is PhytoHealth current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 4108's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 4108's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 4108's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 4108's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 4108 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

I-Lin Lee

0.75

Tenure

I-Lin Lee serves as Director at PhytoHealth Corporation since May 26, 2020 and serves as its President since August 4, 2021. I-Lin Lee experience includes PhytoHealth Corporation AmCad BioMed Corporation L...


Leadership Team

Experienced Management: 4108's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

Experienced Board: 4108's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PhytoHealth Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: PhytoHealth Corporation
  • Ticker: 4108
  • Exchange: TWSE
  • Founded: 1998
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: NT$3.943b
  • Shares outstanding: 198.62m
  • Website: https://www.phytohealth.com.tw

Number of Employees


Location

  • PhytoHealth Corporation
  • No.167, Fu Hsing North Road
  • Floor 5-1
  • Taipei
  • 105
  • Taiwan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/24 00:00
End of Day Share Price2022/05/24 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.